Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Journal of Medical Virology

Changing respiratory pathogens infection patterns after COVID‐19 pandemic in Shanghai, China

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMuyun WeiShanghai Jiao Tong UniversitySLShuangshuang LiHebei University of EngineeringXLXinhua LüChinese Academy of Tropical Agricultural Sciences

Discussion

Loading...

Member takes

Implication

Analysis of inpatient records reveals altered respiratory pathogen infection rates across age groups, highlighting shifted pediatric risks post-pandemic.

Key Points

  • Infection by respiratory pathogens reached 26.07% across 7544 hospitalized patients, with influenza a virus emerging as the most prevalent detected agent overall.
  • Among children, mycoplasma pneumoniae accounted for 35.96% of infections, surpassing human respiratory syncytial virus as the dominant respiratory pathogen.
  • Assessment using multiplex polymerase chain reaction tests indicates that immunosuppression and chronic conditions significantly increase the likelihood of mixed infection.

Cite This Study

Wei et al. (2024) studied this question.

synapsesocial.com/papers/68e70d8cb6db64358768702ehttps://doi.org/10.1002/jmv.29616
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children2015 · 1,894 citations
  2. 2Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis2022 · 2,033 citations
  3. 3Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 20172019 · 183 citations
  4. 4New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase2019 · 34 citations
  5. 5Seasonality of Respiratory Viral Infections2020 · 1,365 citations